
Please try another search
Aptahem AB (publ), a biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. The company’s lead products candidate is Apta-1, which is in preclinical stage to prevent the onset of life-threatening organ and tissue damage in sepsis patients. It has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children’s Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Mikael Lindstam | 59 | 2024 | Co-Founder, CEO & Director |
Bert Junno | 59 | 2020 | Co-Founder & Chairman of the Board |
Anders Bylock | - | 2016 | Chairman of the Scientific Advisory Board |
Theresa Comiskey Olsen | 62 | 2020 | Director |
Mats Eriksson | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review